Osteogenic response of bone marrow stromal cells from normal and ovariectomized rats treated with a low dose of basic fibroblast growth factor

Tissue Engineering

Volumn 13, Issue 4, 2007, Pages 809-817

  Varkey, Mathew ^a   Kucharski, Cezary ^a   Doschak, Michael R ^a   Winn, Shelley R ^b   Brochmann, Elsa J ^c   Murray, Samuel ^c   Matyas, John R ^d   Zernicke, Ronald F ^e   Uludag, Hasan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINITY; CELL GROWTH; DNA; ENZYME KINETICS; FIBROBLASTS; RATS;

ALKALINE PHOSPHATASE (ALP); BASIC FIBROBLAST GROWTH FACTOR (BFGF); BONE MARROW STROMAL CELLS (BMSC); MITOGEN; OSTEOPOROSIS;

BONE;

ALKALINE PHOSPHATASE; DNA; OSTEOPONTIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASPIRATION BIOPSY; BONE DEVELOPMENT; BONE MARROW CELL; BONE MINERALIZATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG SCREENING; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; FEMALE; FEMUR; LOW DRUG DOSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; STROMA CELL; TREATMENT DURATION;

ANIMALS; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBROBLAST GROWTH FACTOR 2; MESENCHYMAL STEM CELLS; OSTEOGENESIS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; STROMAL CELLS; TISSUE ENGINEERING;

ANIMALIA; RATTUS;

EID: 34247483449     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0348     Document Type: Article

References (34)

1. Liu P., Oyajobi B.O., Russell R.G.G., Scutt A. Regulation of osteogenic differentiation of human bone marrow stromal cells: Interaction between transforming growth factor-b and 1,25(OH)2 vitamin D3 in vitro. Calcif. Tissue Int. 65, 173, 1999.
2. Heaney R.P. Remodeling and skeletal fragility. Osteoporos. Int. 14 (Suppl 5), 2003, 12.
3. Scutt A., Bertram P. Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif. Tissue Int. 64, 69, 1999.
4. Nakamura T., Hanada K., Tamura M., Shibanushi T., Nigi H., Tagawa M., Fukumoto S., Matsumoto T. Stimulation of end-osteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 136, 1276, 1995.
5. Nagai H., Tsukuda R., Mayahara H. Effects of basic fibroblast growth factor (bFGF) on bone formation in growing rats. Bone 16, 367, 1995.
6. Zhang X., Sobue T., Hurley M.M. FGF-2 increases colony formation, PTH receptor, and IGF-I mRNA in mouse marrow stromal cells. Biochem. Biophys. Res. Commun. 290,526,2002.
7. Liang H., Pun S., Wronski T.J. Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats. Endocrinology 140, 5780, 1999.
8. Iwaniec U.T., Mosekilde Li., Mitova-Caneva N.G., Thomsen J.S., Wronski T.J. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats. Endocrinology 143,2515,2002.
9. Wronski T.J., Ratkus A.M., Thomsen J.S., Vulcan Q., Mosekilde Li. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats. J. Bone Miner. Res. 16, 1399, 2001.
10. Pun S., Dearden R.L., Ratkus A.M., Liang H., Wronski T.J. Decreased bone anabolic effects of basic fibroblast growth factor at fatty marrow sites in ovariectomized rats. Bone 28, 220, 2001.
11. Power R.A., Iwaniec U.T., Magee K.A., Mitova-Caneva N.G., Wronski T.J. Basic fibroblast growth factor has rapid bone anabolic effects in ovariectomized rats. Osteoporos. Int. 15, 716, 2004.
12. Power R.A., Iwaniec U.T., Wronski T.J. Changes in gene expression associated with the bone anabolic effects of basic fibroblast growth factor in aged ovariectomized rats. Bone 31, 143, 2002.
13. Pun S., Florio C.L., Wronski T.J. Anabolic effects of basic fibroblast growth factor in the tibial diaphysis of ovariectomized rats. Bone 27, 197, 2000.
14. Lane N.E., Kumer J., Yao W., Breunig T., Wronski T., Modin G., Kinney J.H. Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model. Osteoporos. Int. 14, 374, 2003.
15. Iwaniec U.T., Magee K.A., Mitova-Caneva N.G., Wronski T.J. Bone anabolic effects of subcutaneous treatment with basic fibroblast growth factor alone and in combination with estrogen in osteopenic ovariectomized rats. Bone 33, 380, 2003.
16. Lane N.E., Yao W., Kinney J.H., Modin G., Balooch M., Wronski T.J. Both hPTH (1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different-effects on trabecular bone architecture. J. Bone Miner. Res. 18, 2105, 2003.
17. Yao W., Hadi T., Jiang Y., Lotz J., Wronski T.J., Lane N.E. Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats. Osteoporos. Int. 16, 1939, 2005.
18. Wamsley H.L., Iwaniec U.T., Wronski T.J. Selected extraskeletal effects of systemic treatment with basic fibroblast growth factor in ovariectomized rats. Toxicol Pathol 33, 577, 2005.
19. Varkey M., Gittens S.A., Uludag H. Growth factor delivery for bone tissue repair: an update. Expert Opin. Drug Del. 1, 19, 2004.
20. Varkey M., Kucharski C., Haque T., Sebald W., Uludag H. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clin. Orthop. Rel. Res. 443, 113, 2006.
21. Nauman E.A., Sakata T., Keaveny T.M., Halloran B.P., Bikle D.D. bFGF administration lowers the phosphate threshold for mineralization in bone marrow stromal cells. Calcif. Tissue Int. 73, 147, 2003.
22. Janssen J.W., Helbing A.R. Arsenazo III: An improvement of the routine calcium determination in serum. Eur. J. Clin. Chem. Clin. Biochem. 29, 197, 1991.
23. Sun J-S., Chang WH-S., Chena L-T., Huang Y-C., Juang L-W., Lina F-H. The influence on gene-expression profiling of osteoblasts' behavior following treatment with the ionic products of sintered β-dicalcium pyrophosphate dissolution. Biomaterials 25, 607, 2004.
24. Shimuzu E., Matsuda-Honjyo Y., Samoto H., Saito R., Nakajima Y., Nakayama Y., Kato N., Yamazaki M., Ogata Y. Static magnetic fields-induced bone sialoprotein (BSP) expression is mediated through FGF2 response element and pituitary-specific transcription factor-1 motif. J. Cell. Biochem. 91, 1183, 2004.
25. Haque T., Uludag H., Zernicke R.F., Winn S.R., Sebald, W. Bone marrow cells from normal and ovariectomized rats respond differently to basic fibroblast growth factor and bone morphogenetic protein-2 treatment in vitro. Tissue Eng. 11, 634, 2005.
26. Pri-Chen S., Pitaru S., Lokiec F., Savion N. Basic fibroblast growth factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture - enhanced development of mineralized bone-like tissue in culture. Bone 23, 111, 1998.
27. Tanaka H., Ogasa H., Barnes J., Liang C.T. Actions of bFGF on mitogenic activity and lineage expression in rat osteoprogenitor cells: effect of age. Molec. Cell. Endocrinol. 150, 1, 1999.
28. Hanada K., Dennis J.E., Caplan A.I. Stimulatory effects of basic Fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 12, 1606, 1997.
29. Frank O., Heim M., Jakob M., Barbero A., Schäfer D., Bendik I., Dick W., Heberer M., Martin I. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J. Cell. Biochem. 85, 737, 2002.
30. Lisignoli G., Zini N., Remiddi G., Piacentini A., Puggioli A., Trimarchi C., Fini M., Maraldi N.M., Facchini A. Basic fibroblast growth factor enhances in vitro mineralization of rat bone marrow stromal cells grown on non-woven hyaluronic acid based polymer scaffold. Biomaterials 22, 2095, 2001.
31. Kawaguchi H., Chikazu D., Nakamura K., Kumegawa M., Hakeda Y. Direct and indirect actions of Fibroblast Growth Factor 2 on osteoclastic bone resorption in cultures. J. Bone Miner. Res. 15, 466, 2000.
32. Collin-Osdoby P., Rothe L., Bekker S., Anderson F., Huang Y., Osdoby P. Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J. Bone Miner. Res. 17, 1859, 2002.
33. Shimoaka T., Ogasawara T., Yonamine A., Chikazu D., Kawano H., Nakamura K., Itoh N., Kawaguchi H. Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J. Biol. Chem. 277, 7493, 2002.
34. Jimi E., Shuto T., Ikebe T., Jingushi S., Hirata M., Koga T. Basic fibroblast growth factor inhibits osteoclast-like cell formation. J. Cell Physiol. 168, 395, 1996.